docetaxel anhydrous has been researched along with deoxyguanosine in 1 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (deoxyguanosine) | Trials (deoxyguanosine) | Recent Studies (post-2010) (deoxyguanosine) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 6,470 | 225 | 2,167 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishiguro, H; Itcho, N; Kasai, H; Kawai, K; Kobayashi, N; Kubota, Y; Kurioka, D; Okamoto, D; Sato, A; Uemura, H; Watanabe, M | 1 |
1 other study(ies) available for docetaxel anhydrous and deoxyguanosine
Article | Year |
---|---|
Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Deoxyguanosine; DNA; Docetaxel; Humans; Magnetite Nanoparticles; Male; NF-kappa B; Prostatic Neoplasms; Reactive Oxygen Species; Taxoids | 2013 |